GSK Reduces Price of F2 Medicines Early

GlaxoSmithKline (GSK) Australia will reduce the price of F2 medicines impacted by the price disclosure reduction on the 1 March 2012, one month earlier than the Government requirement, to assist pharmacists and minimise any possible disruption to...

01/02/2012

Travel Alert: Don’t risk your health when returning home

Australians visiting family in Asia this holiday season are reminded to make sure their vaccinations are up to date.

13/12/2011

1 in 2 Australians find themselves in a sweat over everyday tasks

Over half of Australians admit finding themselves in a sweat over normal everyday tasks such as sitting at their desks or doing the grocery shopping, according to the GlaxoSmithKline (GSK) Health Index released today.1

24/11/2011

General practice leads the way in innovation with immunisation programs

- Winners of the 2011 GlaxoSmithKline Adult Immunisation Grants announced

19/11/2011

New PBS listing of REVOLADE® (eltrombopag olamine) tablets increases access to treatment options for Australians withchronic ITP

As of 1 November 2011, Australians with the rare blood disorder, chronic immune (idiopathic) thrombocytopenic purpura (ITP), will have increased access to treatment options for chronic ITP with the listing of REVOLADE® (eltrombopag) tablets on the...

10/11/2011

Australian Crohn’s sufferers urged to take part in worldwide research into new treatment

Australians suffering from the debilitating bowel condition, Crohn’s disease (CD), are being invited to participate in a worldwide study to assess a potential new treatment which could alleviate symptoms and improve their quality of life.

09/11/2011

GSK Patient Support Programs Statement

GSK Australia provides patient support programs as part of a commitment to the quality use of medicines only after they have been prescribed a particular medicine/s.

26/10/2011

Final call for 2011 Adult Immunisation Grant applications

GlaxoSmithKline announces final call for healthcare professionals working in immunisation to lodge their application for an Adult Immunisation Grant before entry closes at 5:30pm AEST (Australian Eastern Standard Time) on 19 September 2011, with the...

30/08/2011

GSK Awarded Funds to Advance Dermal Treatment with Starpharma’s Dendrimers

GlaxoSmithKline (GSK), and Starpharma (ASX:SPL, OTCQX:SPHRY) today announced that GSK was awarded a grant to advance a dermal treatment based on Starpharma’s dendrimer drug delivery technology.

22/08/2011

GSK response to July 2011 PBAC meeting outcome

request to extend the National Immunisation Program for pertussis (whooping cough) vaccine to include parents of new-born babies

19/08/2011